Click & View The Digital Mag.
|
Featured articles
The future of the pharmaceutical industry is being driven by the need to not only introduce safe and effective drugs and medical
devices, but to do so in the face of exceptionally demanding economic pressure and competition. Striving to meet these needs has been both challenging and rewarding for eRT.
Roger Clark, Senior Scientist, Cancer & Infection
Department, AstraZeneca, discusses biochemical
screening and the impact of Nautilus.
Ronald D. Fitzmartin shares how DIA has remained strong for over 40 years and why DIA is only becoming bigger and better.
Eric Lindquist, President, Entropy Solutions, discusses a more efficient and green solution to shipping pharmaceutical drugs.
Nancy Grey, Director of Pharmacovigilance education and Process Documentation at Pfizer Inc., discusses the importance of exercising a learning needs analysis.
Moderated by Peter Dibiaso, Senior Clinical Operations Director,
Clinical Research & Development, Shire Pharmaceuticals
David Spaight, President, MDS Pharma Services, discusses
an innovative new study management system that gives
clients access to study data anytime, anywhere
Malcolm Bohm, President, Trialytics, discusses the
frustrations of patient recruitment and methods that
are combating obstacles one measure at a time.
Podcasts
Hilary M. Malone, Ph.D., Senior Vice President and Head of Global Regulatory Affairs for Wyeth and a member of the Wyeth R&D Executive Committee, leads the Regulatory Affairs division that is responsible for Wyeth research and marketed products spanning pharmaceuticals, biopharmaceuticals and vaccines.
While the pharmaceutical industry is rapidly changing, one constant that remains is the need to train and develop quality employees to ensure quality service.
Doug McLeester, VP Supply Chain at sanofi-aventis, leads this panel discussion with experts from Acsis, Inc., Microsoft’s Life Sciences division and SAP to figure out what is changing in terms of industry compliance and how organizations can...
ERIC LINDQUIST, President,
Entropy Solutions, discusses a
more efficient and green solution
to shipping pharmaceutical drugs
p. Ranganath Nayak, Ph.D., Chief Executive Officer of Cytel Inc.,
gives insight into the adaptive clinical trials process.
BARBARA A. PALDUS, MARK SELKER and ALFY RIDDLE,
from Finesse, discuss changes in bioprocessing.
whitepapers
With pharma companies coming under increasing pressure to improve profits and speedproduct development times, how can the industry harness technology to drive down the costof the clinical development process?
The majority of clinical studies fall behind schedule due to slower than expected patient enrollment. Traditional methods that rely on the study site to recruit patients have not evolved and continue to render disappointment that negatively affect the study and often the relationship between “investigator prescribers” and sponsors.
The Center for the Health Professions at the University of California, San Francisco, focuses its efforts on understanding and addressing the challenges faced by health care workers.
In 2000, St. Luke’s Hospital & Health Network was facing a host of industry and operational challenges ranging from staff retention to cost containment to patient satisfaction.
Every year countless businesses that appear to have all the right stuff—great vision and the operational capabilities to implement it—fail. Why? The answer is simple: They fail because they don’t have good leaders.
featured Research
EI is the ability to make the front of the brain rationalize the stimulus prior to assigning it an emotion, thereby affecting the way we look at ourselves and others.
The success of recombinant DNA technology derived biopharmaceuticals has necessitated the construction of large manufacturing plants...
Robert Abraham, Vice President of Oncology at Wyeth Research, provides powerful insight into new methods of preclinical cancer research and the implications it holds for the future of oncology.
Why is the exercise of a learning needs analysis (LNA) so important? Organizations blindly create training for many reasons.
How a firm & its supply chain professionals can enhance their organization by maintaining robust frameworks...
|
|